IP Library Granted Patent US 7,288,570
Granted Patent B2
US 7,288,570 · App. 10/325,711 · Granted Oct 30, 2007

Stimulation of in vivo production of proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,288,570
App. No.
10/325,711
Granted
Oct 30, 2007
Kind
B2
Abstract

The invention relates to a formulation in the form of a pharmaceutical composition, a food product, a feed product or a dietary supplement, comprising leucine and protein in specific amounts. Consumption of a formulation according to the invention has a very positive effect on the generation of muscle tissue and is therefore particularly useful for organisms wherein an anabolic response is desired.

Claims (27)

1. A composition comprising leucine and proteinaceous matter, wherein leucine is present in an amount of at least about 10 wt. % based on a total dry weight of the composition, in a weight ratio of between about 0.2 and 0.4 leucine to other amino acids present in the proteinaceous matter, and in a weight ratio of greater than about 0.48 leucine to a total amount of branched amino acids.

2. The composition of claim 1 , wherein leucine is present in an amount of about 12 to 80 wt. % based on the total dry weight of the composition.

3. The composition of claim 1 , wherein leucine is present in an amount of about 20 to 60 wt. % based on the total dry weight of the composition.

4. The composition of claim 1 , wherein leucine comprises L-leucine.

5. The composition of claim 1 , wherein leucine comprises free leucine.

6. The composition of claim 1 , wherein leucine is present in a weight ratio of between about 0.88 and 20 leucine to a sum of valine and isoleucine.

7. The composition of claim 1 , wherein leucine is present in a weight ratio of between about 1.1 and 10 leucine to a sum of valine and isoleucine.

8. The composition of claim 1 in a daily dosage amount, wherein leucine is present in a weight ratio of between about 0.29 and 0.35 leucine to other amino acids.

9. The composition of claim 1 in a dosage unit, wherein at least about 0.037 grams leucine is present per kilogram bodyweight per dosage unit.

10. The composition of claim 1 in a dosage unit, wherein at least 0.04 grams leucine is present per kilogram bodyweight per dosage unit.

11. The composition of claim 1 , wherein the proteinaceous matter comprises at least about 90 wt. % intact proteins and/or peptides.

12. The composition of claim 1 , wherein the proteinaceous matter is present in an amount such that the composition comprises about 40 to 80 wt. % amino acids, based on the total dry weight of the composition.

13. The composition of claim 1 , wherein the proteinaceous matter is present in such an amount such that the composition comprises about 60 to 75 wt. % amino acids, based on the total dry weight of the composition.

14. The composition of claim 1 further comprising at least about 5 grams of essential amino acids.

15. The composition of claim 14 comprising synthetic L-lysine and/or synthetic L-methionine.

16. The composition of claim 1 further comprising one or more vitamins selected from the group consisting of folic acid, vitamin B6, vitamin B 1, vitamin B2, biotin, lipoic acid, and vitamin B12.

17. The composition of claim 1 further comprising mono- and disaccharides, wherein the mono- and disaccharides are present in an amount of less than about 20 wt. %, based on the total dry weight of the composition.

18. The composition of claim 1 further comprising mono- and disaccharides, wherein the mono- and disaccharides are present in an amount of less than about 10 wt. %, based on the total dry weight of the composition.

19. The composition of claim 1 further comprising mono- and disaccharides, wherein the mono- and disaccharides are present in an amount of less than about 5 wt. %, based on the total dry weight of the composition.

20. The composition of claim 1 , wherein the composition is in a form selected from the group consisting of a pharmaceutical composition, a food product, and a dietary supplement.

21. A food bar comprising:

the composition of claim 1 present in an amount of about 20-40 wt. % of the food bar;

a carbohydrate present in an amount of about 20-40 wt. % of the food bar; and

a lipid present in an amount of about 2-10 wt. % of the food bar.

22. The food bar of claim 21 further comprising conventional food bar ingredients.

23. A composition comprising leucine and proteinaceous matter, wherein leucine is present in an amount of at least about 10 wt. % based on a total dry weight of the composition, wherein leucine is present in a weight ratio of between about 0.2 and 0.4 leucine to other amino acids present in the proteinaceous matter, wherein the leucine is present in a weight ratio of greater than about 0.48 leucine to a total amount of branched amino acids, and wherein a total amount of amino acids and peptides is 50% or less than the total amount of the proteinaceous matter.

24. A composition comprising leucine and proteinaceous matter, wherein leucine is present in an amount of at least about 10 wt. % based on a total dry weight of the composition, wherein leucine is present in a weight ratio of between about 0.2 and 0.4 leucine to other amino acids present in the proteinaceous matter, wherein the leucine is present in a weight ratio of greater than about 0.48 leucine to a total amount of branched amino acids, and wherein a total amount of amino acids and peptides is 30% or less than the total amount of the proteinaceous matter.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2020
From: GLAS TRUST COMPANY LLC, AS COLLATERAL AGENT (AS SUCCESSOR TO JPMORGAN CHASE BANK, N.A.)
To: GNC CORPORATION; GENERAL NUTRITION CENTERS, INC.; GENERAL NUTRITION CORPORATION; GNC TRANSPORTATION, LLC; GNC FUNDING, INC.; GENERAL NUTRITION INVESTMENT COMPANY
Reel/Frame 054015/0001 →
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (025958/0631) Recorded Jun 1, 2020
From: JPMORGAN CHASE BANK, N.A.
To: GLAS TRUST COMPANY LLC
Reel/Frame 052804/0979 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2016
From: GENERAL NUTRITION INVESTMENT COMPANY
To: N.V. NUTRICIA
Reel/Frame 038446/0353 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2016
From: N.V. NUTRICIA
To: AJINOMOTO CO., INC.
Reel/Frame 038446/0493 →
SECURITY AGREEMENT Recorded Mar 15, 2011
From: GNC CORPORATION; GENERAL NUTRITION CENTERS, INC.; GENERAL NUTRITION CORPORATION; GENERAL NUTRITION INVESTMENT COMPANY; GNC TRANSPORTATION, LLC; GNC FUNDING, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 025958/0631 →
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2011
From: JPMORGAN CHASE BANK, N.A.
To: GENERAL NUTRITION INVESTMENT COMPANY
Reel/Frame 025905/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2007
From: N.V. NUTRICIA
To: GENERAL NUTRITION INVESTMENT COMPANY
Reel/Frame 019955/0955 →
RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 14934/0916 Recorded Apr 9, 2007
From: LEHMAN COMMERCIAL PAPER, INC.
To: GENERAL NUTRITION CORPORATION
Reel/Frame 019134/0223 →
SECURITY AGREEMENT Recorded Dec 30, 2003
From: GENERAL NUTRITION CORPORATION
To: LEHMAN COMMERCIAL PAPER INC., AS ADMINISTRATIVE AGENT
Reel/Frame 014934/0916 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2003
From: VERLAAN, GEORGE; SMEETS, RUDOLF LEONARDUS LODEWIJK; WOLFE, ROBERT REESE
To: NUTRICIA N.V.
Reel/Frame 014084/0012 →